)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
iSpecimen
iSpecimen (ISPC) investor relations material
iSpecimen EGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.EGM 2026 summary30 Oct, 2026
Opening remarks and agenda
Reconvened session began Oct. 30, 2026, to address only proposal 2; proposals 1, 3, 4 and 5 were acted on Oct. 9, 2026.
No other business was scheduled; the meeting was adjourned after the vote on proposal 2.
Specific resolutions to be voted on
Proposal 2 sought an amendment to the certificate of incorporation authorizing a 1-for-10 to 1-for-100 reverse split of outstanding common shares, with the board setting the exact ratio without further stockholder approval.
Approval required votes cast for the proposal to exceed votes cast against; abstentions had no effect, and brokers could vote uninstructed shares at their discretion.
Board and executive committee updates
The board unanimously recommended voting for proposal 2 and had determined the proposal’s voting standard by unanimous written consent on Oct. 9, 2026.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from iSpecimen
- Nevada conversion leads the agenda as Nasdaq equity compliance remains at risk.ISPC
Proxy filing - Reverse split vote resumes Oct. 30 under a FOR-versus-AGAINST standard.ISPCProxy filing
- Four proposals cleared preliminary voting; the reverse-split vote stays open through Oct. 30.ISPCAGM 2026
- Reverse-split vote adjourned to October 30 under a votes-for-must-exceed-against standard.ISPCProxy filing
- Special Meeting seeks approval for stock issuances, reverse split, and AI asset acquisition.ISPCProxy filing
- Stockholders will vote on share issuances, a reverse split, and an AI asset acquisition.ISPCProxy filing
- Revenue fell 83% and net loss widened, raising substantial doubt about going concern status.ISPCQ2 2026
- Raising up to $5M via best-efforts offering to fund operations, marketing, and platform growth.ISPCRegistration filing
- Biospecimen marketplace seeks up to $4M via Nasdaq offering amid ongoing losses and liquidity risks.ISPCRegistration filing
Next iSpecimen earnings date
Q3 202613 Nov, 2026
iSpecimen
Next iSpecimen earnings date
Q3 202613 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
iSpecimen Inc. is a technology-driven company that connects researchers with human biospecimens for medical research and development. Through its proprietary online marketplace, the company facilitates the procurement of biological samples, including blood, tissue, and other biofluids, from a global network of healthcare providers. iSpecimen serves pharmaceutical companies, biotechnology firms, academic institutions, and government organizations involved in drug discovery, diagnostics, and precision medicine. iSpecimen Inc. is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.